Coherus BioSciences, Inc. announced that it has received $38.7 million in a round of funding on May 9, 2024. The company has issued term loan in the transaction. The loan will mature in May 2029.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.82 USD | -3.19% | -4.71% | -45.35% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.35% | 209M | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- CHRS Stock
- News Coherus BioSciences, Inc.
- Coherus BioSciences, Inc. announced that it has received $38.7 million in funding